Jeffrey Canlobo
About Jeffrey Canlobo
Jeffrey Canlobo is a Quality Engineering Manager at Capricor Therapeutics, Inc., where he has worked since 2022. He has a background in bioengineering and has held various quality engineering roles, including at CAPTEK® Softgel International and Gilead Sciences.
Work at Capricor Therapeutics
Jeffrey Canlobo serves as the Quality Engineering Manager at Capricor Therapeutics, Inc., a position he has held since 2022. In this role, he manages the facilities department and oversees program development. He is responsible for the installation and system ownership of the Environmental Monitoring System for critical equipment and facilities. Canlobo has developed and generated Validation Master Plans for two facilities, ensuring compliance with industry standards. His expertise includes managing quality systems such as calibrations and preventive maintenance.
Previous Experience at CAPTEK® Softgel International
Prior to his current role, Jeffrey Canlobo worked as a Validation Specialist at CAPTEK® Softgel International from 2015 to 2022. During his seven years there, he contributed to various validation processes and compliance measures. His experience at CAPTEK® provided him with a solid foundation in quality engineering practices, which he has applied in subsequent positions.
Experience at Gilead Sciences
In 2022, Jeffrey Canlobo briefly worked as a Quality Engineer II at Gilead Sciences for seven months. His role involved ensuring quality standards and compliance within the organization. This experience further enhanced his skills in quality engineering and risk assessment.
Education and Expertise
Jeffrey Canlobo holds a Bachelor of Science (B.S.) degree in Bioengineering and Biomedical Engineering from the University of California, Riverside, where he studied from 2009 to 2013. He furthered his education by obtaining a Master of Science (M.S.) in the same field from San Diego State University, completing his studies from 2014 to 2016. His academic background provides him with a strong foundation in engineering principles and practices relevant to the biomedical field.
Professional Contributions
In his current role, Jeffrey Canlobo has developed and is the system owner of all risk assessments for Capricor Therapeutics, including Failure Mode and Effects Analyses (FMEAs). He has supported tech transfer and gap assessments for new product introductions and site-to-site product transfers. Additionally, he has developed and revised various systems, including equipment logbooks, Standard Operating Procedures (SOPs), pest control measures, Lockout/Tagout (LOTO) procedures, batch record development, and Environmental Monitoring protocols.